AliveCor | Newsroom

Auszeichnungen

Nach Jahr filtern

Für Presseanfragen wenden Sie sich bitte an press@alivecor.com

Most Recent

9. Juli 2026

Article: The Future of ECG Begins with Better Signals

Artikel lesen

6. Mai 2026

Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk

Artikel lesen

15. April 2026

AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design

Artikel lesen

2. April 2026

WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

Artikel lesen

20. Februar 2026

Ametris and AliveCor Announce Strategic Partnership to Expand Cardiac Safety Monitoring Capabilities in Clinical Research

Artikel lesen

13. Januar 2026

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

Artikel lesen

4. Dezember 2025

Thatch Partners with AliveCor to Offer KardiaCare Plus Through Its Marketplace

Artikel lesen

3. November 2025

Hannover Medical School pioneers integration of GE HealthCare and AliveCor technologies to enhance cardiac care

Artikel lesen

24. Juli 2025

AliveCor Launches First-of-its-Kind AI-Powered Kardia 12L ECG System in India

Artikel lesen

2. Juni 2025

AliveCor and British Heart Foundation Join Forces in a Year-Long Campaign

Artikel lesen

6. Mai 2025

AliveCor Launches AI-Powered KardiaMobile 6L Max and KardiaAlert to Deliver the Most Advanced Personal ECG Solution on the Market

Artikel lesen

16. Januar 2025

Kardia 12L ECG System Receives CMS Reimbursement Approval

Artikel lesen

14. Januar 2025

New Study Shows AliveCor's Kardia 12L ECG System Performs Equivalently to a Standard 12-Lead ECG

Artikel lesen

5. Dezember 2024

AliveCor’s Kardia 12L ECG System Awarded Inc.’s 2024 Best in Business Awards

Artikel lesen

24. November 2024

AliveCor's Services & Solutions are Now Available to Veterans

Artikel lesen

23. Juli 2024

Former Lions and Wales Rugby Captain Alun Wyn Jones partners with AliveCor to launch ‘Let’s Talk Rhythm’ campaign to raise awareness of atrial fibrillation

Artikel lesen

17. Juli 2024

AliveCor’s Kardia 12L ECG System Receives Category III CPT Codes

Artikel lesen

9. Juli 2024

Introduction of AliveCor's revolutionary InstantQT® solution set to streamline ECG evaluation and enhance patient safety across Europe

Artikel lesen

25. Juni 2024

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

Artikel lesen

5. Juni 2024

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

Artikel lesen

18. Dezember 2023

AliveCor Expands eHealth Service to Android Users

Artikel lesen

10. November 2023

AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise

Artikel lesen

26. September 2023

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

Artikel lesen

20. Juni 2023

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

Artikel lesen

3. Mai 2023

AliveCor’s KardiaMobile Card Awarded Fast Company’s 2023 World Changing Ideas Awards and 2023 MedTech Breakthrough Awards

Artikel lesen

21. Februar 2023

AliveCor Announces the ITC's Limited Exclusion Order Against Apple Clears Presidential Review

Artikel lesen

22. Dezember 2022

ITC Rules Apple Violated AliveCor’s Patents

Artikel lesen

17. November 2022

AliveCor's KardiaMobile Card Honored by the 2022 Fierce Life Sciences Innovation Awards and the 2023 CES® Innovation Awards

Artikel lesen

16. August 2022

AliveCor Announces Series F Financing to Help Expand Offerings to Key Healthcare Industry Stakeholders

Artikel lesen

27. Juni 2022

ITC Administrative Law Judge Finds Apple Infringed AliveCor’s Patented Technology

Artikel lesen

3. Mai 2022

AliveCor Launches KardiaComplete to Help Reduce the Rising Health and Economic Costs of Heart Disease

Artikel lesen

10. Februar 2022

ALIVECOR APPOINTS PATRICIA BARAN TO SERVE AS SENIOR VICE PRESIDENT, HEALTHCARE AMERICAS

Artikel lesen

1. Februar 2022

FDA Clears World’s First Credit-Card-Sized Personal ECG

Artikel lesen

11. Januar 2022

AliveCor Announces Strategic Additions to Executive Team

Artikel lesen

20. Dezember 2021

AliveCor Lists its Industry-leading KardiaMobile 6L in Epic's App Orchard Marketplace

Artikel lesen

12. Oktober 2021

AliveCor Launches AliveCor Labs

Artikel lesen

1. September 2021

KardiaMobile 6L is Superior to One Lead Personal Devices

Artikel lesen

27. Juli 2021

New Study Demonstrates KardiaMobile 6L Reduces Urgent Healthcare Utilization

Artikel lesen

27. Juli 2021

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

Artikel lesen

8. Juli 2021

FDA Clears Personal ECG Device for Measurement of QTc Interval, a Critical Marker for Patient Safety

Artikel lesen

2. Juni 2021

AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services

Artikel lesen

26. Mai 2021

Apple Abused Market Power in Cardio Device Market, Suit Alleges

Artikel lesen

21. Mai 2021

ITC Formally Commences Investigation into Apple Watch Infringement of AliveCor Patents

Artikel lesen

20. April 2021

AliveCor Files ITC Complaint Seeking to Bar U.S. Importation of Apple Watch

Artikel lesen

9. März 2021

AliveCor Appoints Clyde Hosein as Chief Financial Officer

Artikel lesen

16. Februar 2021

AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions

Artikel lesen

1. Februar 2021

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

Artikel lesen

23. November 2020

FDA Clears First of its Kind Algorithm Suite for Personal ECG

Artikel lesen

16. November 2020

AliveCor Closes $65 Million Financing to Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, and Providers

Artikel lesen

9. November 2020

AliveCor Appoints Toby Cosgrove, M.D. to Board of Directors

Artikel lesen

25. September 2020

AliveCor Brings World's Only Six-lead, FDA-cleared Personal ECG to India

Artikel lesen

9. Juli 2020

AliveCor Expands Telemedicine Services to Support Heart Care at Home

Artikel lesen

6. Mai 2020

AliveCor Partners with The Clifford Lab at Emory University and Georgia Institute of Technology

Artikel lesen

23. April 2020

AliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring

Artikel lesen

13. April 2020

AliveCor to Provide QTc Measurement for Clinicians Treating COVID-19 Patients

Artikel lesen

23. März 2020

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

Artikel lesen

19. Februar 2020

AliveCor Receives Approval to Launch KardiaMobile in Mexico

Artikel lesen

30. Oktober 2019

AliveCor and Huami Partner To Deliver The Next Generation of Medical Wearables

Artikel lesen

10. September 2019

Olympic Icon Mark Spitz Partners with AliveCor To Build Awareness Around Heart Health

Artikel lesen

24. Juli 2019

AliveCor Appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board

Artikel lesen

13. Mai 2019

FDA Grants First Ever Clearance For Six-Lead Personal ECG Device

Artikel lesen

23. April 2019

FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device

Artikel lesen

22. April 2019

New AliveCor Partnership Marks Expansion into Chinese Heart Health Market

Artikel lesen

18. März 2019

Three New Studies Confirm Clinical Utility of AliveCor's KardiaMobile Device and AI Algorithms

Artikel lesen

26. Februar 2019

AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer

Artikel lesen

12. November 2018

AliveCor's Mobile ECG Technology Could Enable More Rapid Diagnosis and Treatment of Heart Attacks

Artikel lesen

12. November 2018

AliveCor AI Found to Compare Favorably to Surgically Implanted Loop Recorder

Artikel lesen

10. September 2018

FDA Designates AliveCor’s Bloodless Hyperkalemia Test a “Breakthrough Device.”

Artikel lesen

10. Mai 2018

Previously Invisible Long QT Syndrome Now Observable With Machine Learning

Artikel lesen

5. April 2018

AliveCor Data Yield Reaches 25MM ECGs Largest Data Set of Any Consumer ECG Device

Artikel lesen

12. März 2018

Cleveland Clinic Study Affirms Accurate Detection of Atrial Fibrillation by KardiaBand for Apple Watch

Artikel lesen

20. Februar 2018

AliveCor Named No.1 Artificial Intelligence Company in Fast Company’s 2018 Most Innovative Companies Ranking

Artikel lesen

12. Dezember 2017

AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias

Artikel lesen

30. November 2017

FDA Clears First Medical Device Accessory for Apple Watch®

Artikel lesen

6. September 2017

New Research Confirms Significance of AliveCor’s 30 Second EKG

Artikel lesen

19. Juli 2017

AI That Sees the Invisible: AliveCor and Mayo Clinic Announce Collaboration to Develop Groundbreaking AI Technology to Help Prevent Sudden Cardiac Death

Artikel lesen

16. März 2017

AliveCor Unveils First AI-Enabled Platform for Doctors to Improve Stroke Prevention Through Early Atrial Fibrillation Detection

Artikel lesen

13. Februar 2017

AliveCor Named to Fast Company's Top 10 Most Innovative Companies in Health

Artikel lesen

28. Oktober 2016

Launch of world’s smallest single lead ECG

Artikel lesen

28. Oktober 2016

AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke

Artikel lesen

28. Oktober 2016

New medical grade single lead ECG on your WRIST helps discover possible Atrial Fibrillation, a leading cause of stroke in the UK

Artikel lesen

24. Oktober 2016

AliveCor and Mayo Clinic Announce Collaboration to Identify Hidden Health Signals in Humans

Artikel lesen

18. Mai 2016

Clinical Research From HRS Validates AliveCor Delivers Value-Based Care for Heart Health

Artikel lesen

21. März 2016

New AliveCor Leaders Further AliveCor’s Momentum in Wearable MedTech

Artikel lesen

16. März 2016

New Kardia™ Band for Apple Watch Delivers Medical-grade Electrocardiogram (EKG) Anytime, Anywhere

Artikel lesen

12. Januar 2016

AliveCor Partners with LifeWatch to Expand Into Remote Patient

Artikel lesen

12. November 2015

AliveCor and ILLIES Announce New Distribution Agreement in Hong Kong and Macau

Artikel lesen

11. November 2015

AliveCor Announces Appointment of Chief Executive Officer

Artikel lesen

9. September 2015

AliveCor Mobile ECG Shows Momentum as Tool for AFib Detection

Artikel lesen

5. August 2015

AliveCor Awarded as Technology Pioneer by World Economic Forum

Artikel lesen

18. Juni 2015

AliveCor Announces Availability of its Mobile ECG in Canada

Artikel lesen

16. Juni 2015

AliveCor Launches Updated App that Provides New Heart Journal

Artikel lesen

19. März 2015

AliveCor Launches Third Generation Heart Monitor in the UK & Ireland

Artikel lesen

16. März 2015

AliveCor and Preventice Solutions Launch Pilot Cloud-Based Analytics Program

Artikel lesen

9. März 2015

AliveCor Launches New App that Automatically Tells Patients When Their ECG Recording is Normal

Artikel lesen

29. Januar 2015

AliveCor Announces FDA Clearance for Two New Automated Detectors for Normal Recordings and Noise Interference

Artikel lesen

22. Januar 2015

AliveCor Launches Ability to Detect A Serious Heart Condition in an ECG on a Mobile Device

Artikel lesen

5. Januar 2015

Study Results from Cleveland Clinic’s iTransmit Study Published in

Artikel lesen

18. Dezember 2014

AliveCor Launches Third Generation Heart Monitor Advancing the Future of Heart Health

Artikel lesen

9. Dezember 2014

Omron Healthcare and AliveCor Collaborate for Heart Health

Artikel lesen

16. November 2014

AliveCor® to Showcase the AliveCor Heart Monitor at the American Heart

Artikel lesen

21. Oktober 2014

AliveCor Honored as one of FierceMedicalDevices’ Fierce 15 Most Promising Private Medical and Diagnostic Companies in the World

Artikel lesen

29. September 2014

AliveCor Launches New App to Auto Detect Atrial Fibrillation in an ECG Recording

Artikel lesen

21. August 2014

AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device

Artikel lesen

17. Juli 2014

One Million ECGs Recorded with the AliveCor® Heart Monitor

Artikel lesen

2. Juni 2014

Free Heart Screenings Available in More than 100 Pharmacies in North East London

Artikel lesen

19. Mai 2014

Studies Presented at Heart Rhythm 2014 Demonstrate Accuracy of the AliveCor® Heart Monitor and Confirm Patient Satisfaction

Artikel lesen

8. Mai 2014

AliveCor Introduces First iOS App Combining ECG and Blood Pressure to Manage Heart Health

Artikel lesen

2. April 2014

AliveCor Announces Results of SEARCH-AF Trial

Artikel lesen

18. März 2014

AliveCor Continues To Improve Its Service Offerings

Artikel lesen

3. März 2014

ALIVECOR EXPERT ECG ANALYSIS SERVICE NOW AVAILABLE IN UK AND IRELAND

Artikel lesen

24. Februar 2014

AliveCor Offers Integration With Practice Fusion's Electronic Health Records Platform

Artikel lesen

10. Februar 2014

ALIVECOR RECEIVES FDA OVER-THE-COUNTER CLEARANCE FOR ITS HEART MONITOR

Artikel lesen

18. November 2013

AliveCor Transforms Heart Monitor into eHealth Service

Artikel lesen

24. Oktober 2013

AliveCor Supports UCSF’s Online Health eHeart Study

Artikel lesen

4. Oktober 2013

AliveCor Unveils Versatile Mobile Heart Monitor

Artikel lesen

23. August 2013

AliveCor Launches New Feature to Enhance Visual Quality of ECG

Artikel lesen

24. Juni 2013

AliveCor Expands Mobile ECG Device Offering to United Kingdom & Ireland

Artikel lesen

3. Juni 2013

U.K. Hospitals to Use New AliveCor Heart Monitor During Heart Rhythm

Artikel lesen

8. Mai 2013

AliveCor Expands Mobile ECG Device Offering to Include iPhone 5

Artikel lesen

8. März 2013

AliveCor Mobile ECG Device for Heart Rhythm Monitoring Now Available by Prescription

Artikel lesen

3. Dezember 2012

AliveCor’s Heart Monitor for iPhone Receives FDA Clearance

Artikel lesen

7. November 2012

Study Points to Mobile Device as Breakthrough for Community Screening and Stroke Prevention

Artikel lesen

10. September 2012

AliveCor Delivers Breakthrough Mobile ECG Device for Veterinarians

Artikel lesen

11. Juni 2012

AliveCor Raises $10.5M in Series B Financing

Artikel lesen

11. Mai 2012

AliveCor Announces Smartphone Electrocardiogram Demonstrates Accuracy in Monitoring Patients’ Heart Health

Artikel lesen

27. März 2012

First Wireless Smartphone Electrocardiogram Demonstrates Success in Monitoring Patients’ Heart Health

Artikel lesen

Erforschende Nutzung

Die als „erforschende Nutzung“ gekennzeichnete Forschung wurde mit AliveCor-Geräten auf erforschende Weise durchgeführt und untersucht potenzielle zukünftige Geräte und Konfigurationen. Die in dieser Forschung verwendeten Geräte und Konfigurationen sind derzeit nicht kommerziell erhältlich. AliveCor kann diese nach Abschluss der entsprechenden regulatorischen Verfahren künftig verfügbar machen. VORSICHT: Die in der als „erforschende Nutzung“ gekennzeichneten Forschung verwendeten Geräte sind für erforschende Nutzung. Durch Bundesrecht (USA) nur auf erforschende Nutzung beschränkt. Klicken Sie hier, um Zugang zu den Studien zur erforschenden Nutzung zu erhalten.

Pressemitteilungen

Auszeichnungen

Digital Health Awards Spring 2022

Edison Awards 2025

New York Product Design Awards 2024

Fierce Healthcare Innovation Awards 2022

Fast Company's World Changing Ideas Award 2023

TIME World's Top HealthTech Companies of 2025

Inc. Magazine's 2024 Best in Business Award Winner

Digital Health Awards Spring 2024

Medtech Breakthrough Awards for Best New Technology Solution 2023

Inc. 2023 Best in Business Honoree

Most Recent

Article: The Future of ECG Begins with Better Signals

Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk

AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design

WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

Ametris and AliveCor Announce Strategic Partnership to Expand Cardiac Safety Monitoring Capabilities in Clinical Research

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

Thatch Partners with AliveCor to Offer KardiaCare Plus Through Its Marketplace

Hannover Medical School pioneers integration of GE HealthCare and AliveCor technologies to enhance cardiac care

AliveCor Launches First-of-its-Kind AI-Powered Kardia 12L ECG System in India

AliveCor and British Heart Foundation Join Forces in a Year-Long Campaign

AliveCor Launches AI-Powered KardiaMobile 6L Max and KardiaAlert to Deliver the Most Advanced Personal ECG Solution on the Market

Kardia 12L ECG System Receives CMS Reimbursement Approval

New Study Shows AliveCor's Kardia 12L ECG System Performs Equivalently to a Standard 12-Lead ECG

AliveCor’s Kardia 12L ECG System Awarded Inc.’s 2024 Best in Business Awards

AliveCor's Services & Solutions are Now Available to Veterans

Former Lions and Wales Rugby Captain Alun Wyn Jones partners with AliveCor to launch ‘Let’s Talk Rhythm’ campaign to raise awareness of atrial fibrillation

AliveCor’s Kardia 12L ECG System Receives Category III CPT Codes

Introduction of AliveCor's revolutionary InstantQT® solution set to streamline ECG evaluation and enhance patient safety across Europe

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

AliveCor Expands eHealth Service to Android Users

AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

AliveCor’s KardiaMobile Card Awarded Fast Company’s 2023 World Changing Ideas Awards and 2023 MedTech Breakthrough Awards

AliveCor Announces the ITC's Limited Exclusion Order Against Apple Clears Presidential Review

ITC Rules Apple Violated AliveCor’s Patents

AliveCor's KardiaMobile Card Honored by the 2022 Fierce Life Sciences Innovation Awards and the 2023 CES® Innovation Awards

AliveCor Announces Series F Financing to Help Expand Offerings to Key Healthcare Industry Stakeholders

ITC Administrative Law Judge Finds Apple Infringed AliveCor’s Patented Technology

AliveCor Launches KardiaComplete to Help Reduce the Rising Health and Economic Costs of Heart Disease

ALIVECOR APPOINTS PATRICIA BARAN TO SERVE AS SENIOR VICE PRESIDENT, HEALTHCARE AMERICAS

FDA Clears World’s First Credit-Card-Sized Personal ECG

AliveCor Announces Strategic Additions to Executive Team

AliveCor Lists its Industry-leading KardiaMobile 6L in Epic's App Orchard Marketplace

AliveCor Launches AliveCor Labs

KardiaMobile 6L is Superior to One Lead Personal Devices

New Study Demonstrates KardiaMobile 6L Reduces Urgent Healthcare Utilization

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

FDA Clears Personal ECG Device for Measurement of QTc Interval, a Critical Marker for Patient Safety

AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services

Apple Abused Market Power in Cardio Device Market, Suit Alleges

ITC Formally Commences Investigation into Apple Watch Infringement of AliveCor Patents

AliveCor Files ITC Complaint Seeking to Bar U.S. Importation of Apple Watch

AliveCor Appoints Clyde Hosein as Chief Financial Officer

AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

FDA Clears First of its Kind Algorithm Suite for Personal ECG

AliveCor Closes $65 Million Financing to Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, and Providers

AliveCor Appoints Toby Cosgrove, M.D. to Board of Directors

AliveCor Brings World's Only Six-lead, FDA-cleared Personal ECG to India

AliveCor Expands Telemedicine Services to Support Heart Care at Home

AliveCor Partners with The Clifford Lab at Emory University and Georgia Institute of Technology

AliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring

AliveCor to Provide QTc Measurement for Clinicians Treating COVID-19 Patients

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

AliveCor Receives Approval to Launch KardiaMobile in Mexico

AliveCor and Huami Partner To Deliver The Next Generation of Medical Wearables

Olympic Icon Mark Spitz Partners with AliveCor To Build Awareness Around Heart Health

AliveCor Appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board

FDA Grants First Ever Clearance For Six-Lead Personal ECG Device

FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device

New AliveCor Partnership Marks Expansion into Chinese Heart Health Market

Three New Studies Confirm Clinical Utility of AliveCor's KardiaMobile Device and AI Algorithms

AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer

AliveCor's Mobile ECG Technology Could Enable More Rapid Diagnosis and Treatment of Heart Attacks

AliveCor AI Found to Compare Favorably to Surgically Implanted Loop Recorder